X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4761) 4761
Publication (477) 477
Book Review (26) 26
Book Chapter (11) 11
Book / eBook (9) 9
Conference Proceeding (6) 6
Magazine Article (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dronabinol - pharmacology (3468) 3468
animals (3261) 3261
male (2712) 2712
humans (1900) 1900
rats (1619) 1619
pharmacology & pharmacy (1151) 1151
mice (1149) 1149
female (1146) 1146
index medicus (1051) 1051
dose-response relationship, drug (954) 954
dronabinol - analogs & derivatives (828) 828
dronabinol - administration & dosage (739) 739
time factors (696) 696
neurosciences (695) 695
adult (668) 668
cannabis (625) 625
cannabinoids (624) 624
cannabinoids - pharmacology (592) 592
marijuana (542) 542
cannabis - pharmacology (536) 536
tetrahydrocannabinol (479) 479
behavior, animal - drug effects (432) 432
dronabinol - metabolism (407) 407
pyrazoles - pharmacology (397) 397
delta-9-tetrahydrocannabinol (394) 394
piperidines - pharmacology (391) 391
rats, sprague-dawley (384) 384
psychiatry (383) 383
motor activity - drug effects (352) 352
thc (352) 352
brain - drug effects (333) 333
delta-tetrahydrocannabinol (315) 315
receptors, cannabinoid (311) 311
dronabinol - therapeutic use (308) 308
in vitro techniques (307) 307
brain - metabolism (303) 303
drug interactions (299) 299
endocannabinoids (279) 279
cannabinoid (274) 274
drug tolerance (256) 256
article (252) 252
cannabidiol - pharmacology (248) 248
middle aged (239) 239
dronabinol - adverse effects (238) 238
heart rate - drug effects (238) 238
dronabinol - blood (237) 237
brain (231) 231
double-blind method (231) 231
dronabinol (230) 230
rats, wistar (225) 225
cannabidiol (224) 224
receptor, cannabinoid, cb1 - metabolism (222) 222
psychotropic drugs - pharmacology (210) 210
adolescent (204) 204
arachidonic acids - pharmacology (201) 201
anandamide (198) 198
pharmacology (197) 197
dronabinol - toxicity (191) 191
mental disorders (191) 191
rats, inbred strains (188) 188
administration, oral (187) 187
receptor, cannabinoid, cb1 - agonists (187) 187
young adult (187) 187
mice, inbred c57bl (184) 184
dronabinol - analysis (182) 182
receptor, cannabinoid, cb1 - antagonists & inhibitors (177) 177
cells, cultured (176) 176
body temperature - drug effects (173) 173
hallucinogens - pharmacology (169) 169
kinetics (169) 169
rimonabant (167) 167
endocannabinoid system (166) 166
naphthalenes - pharmacology (162) 162
receptor (161) 161
morpholines - pharmacology (159) 159
blood pressure - drug effects (158) 158
dronabinol - pharmacokinetics (158) 158
biochemistry & molecular biology (149) 149
inhibition (148) 148
disease models, animal (146) 146
structure-activity relationship (145) 145
rat (144) 144
analysis of variance (143) 143
cannabinoid receptor (141) 141
analysis (140) 140
rat-brain (140) 140
clinical neurology (138) 138
dronabinol - antagonists & inhibitors (138) 138
analgesics - pharmacology (137) 137
cannabis - chemistry (137) 137
conditioning, operant - drug effects (135) 135
rabbits (135) 135
pregnancy (134) 134
drug synergism (132) 132
reaction time - drug effects (132) 132
receptors, drug - metabolism (132) 132
psychomotor performance - drug effects (131) 131
mice, inbred icr (130) 130
morphine - pharmacology (129) 129
cyclohexanols - pharmacology (128) 128
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4666) 4666
French (37) 37
German (23) 23
Russian (13) 13
Japanese (11) 11
Spanish (9) 9
Norwegian (7) 7
Chinese (3) 3
Dutch (3) 3
Hebrew (2) 2
Italian (2) 2
Portuguese (2) 2
Afrikaans (1) 1
Czech (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 01/2010, Volume 30, Issue 2, pp. 545 - 555
Marijuana is a widely used drug that impairs memory through interaction between its psychoactive constituent, Delta-9-tetrahydrocannabinol (Delta(9)-THC), and... 
CA1 Region, Hippocampal - cytology | Receptor, Adenosine A1 - physiology | Neurons - cytology | Xanthines - pharmacology | Excitatory Postsynaptic Potentials - drug effects | Patch-Clamp Techniques - methods | Receptor, Cannabinoid, CB1 - physiology | Excitatory Postsynaptic Potentials - physiology | Quinoxalines - pharmacology | Neural Inhibition - physiology | Receptor, Cannabinoid, CB1 - agonists | Piperidines - pharmacology | Caffeine - pharmacology | Dronabinol - pharmacology | Electric Stimulation - methods | Pyrazoles - pharmacology | Presynaptic Terminals - drug effects | Mice, Inbred C57BL | Morpholines - pharmacology | Excitatory Amino Acid Agonists - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Biophysics | Calcium Channel Blockers - pharmacology | GABA Antagonists - pharmacology | Mice, Knockout | Naphthalenes - pharmacology | Methoxyhydroxyphenylglycol - analogs & derivatives | Methoxyhydroxyphenylglycol - pharmacology | Animals | Analysis of Variance | Phosphinic Acids - pharmacology | Benzoxazines - pharmacology | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - pharmacology | Adenosine - metabolism | Picrotoxin - pharmacology | Presynaptic Terminals - metabolism | Glutamic Acid - metabolism | Mice | Receptor, Cannabinoid, CB1 - deficiency | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | In Vitro Techniques | Propanolamines - pharmacology | Neural Inhibition - drug effects
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 04/2004, Volume 19, Issue 7, pp. 1826 - 1836
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 01/2009, Volume 29, Issue 2, pp. 393 - 401
Glucocorticoids exert an opposing rapid regulation of glutamate and GABA synaptic inputs to hypothalamic magnocellular neurons via the activation of... 
GABA | Magnocellular neuron | Endocannabinoid | Glucocorticoid | Nitric oxide | SUPRAOPTIC NUCLEUS | endocannabinoid | glucocorticoid | nitric oxide | ACTIVATION | magnocellular neuron | NITRIC-OXIDE SYNTHASE | NEUROSCIENCES | MEMBRANE ESTROGEN-RECEPTORS | ENDOCANNABINOID RELEASE | PARAVENTRICULAR NUCLEUS | G(alpha) | ADRENALECTOMIZED RATS | NEURONS | VASOPRESSIN | OXYTOCIN | G(beta)gamma | Cannabinoid Receptor Modulators - metabolism | Synaptic Transmission - physiology | gamma-Aminobutyric Acid - metabolism | GTP-Binding Proteins - antagonists & inhibitors | Male | Penicillamine - analogs & derivatives | Patch-Clamp Techniques - methods | Quinoxalines - pharmacology | Dexamethasone - pharmacology | Piperidines - pharmacology | Dronabinol - analogs & derivatives | Neurons - physiology | Nitric Oxide Donors - pharmacology | Dronabinol - pharmacology | Neurons - drug effects | Electric Stimulation - methods | Pyrans - pharmacology | Guanosine Diphosphate - pharmacology | Pyrazoles - pharmacology | Cyclic AMP-Dependent Protein Kinases - metabolism | Synapses - drug effects | Synapses - physiology | Penicillamine - pharmacology | Valine - analogs & derivatives | Enzyme Inhibitors - pharmacology | Rats | Excitatory Amino Acid Antagonists - pharmacology | Thionucleotides - pharmacology | Rats, Sprague-Dawley | Animals | Guanosine Diphosphate - analogs & derivatives | Hypothalamus - cytology | Signal Transduction - drug effects | Arginine - pharmacology | Cannabinoid Receptor Modulators - antagonists & inhibitors | Glucocorticoids - pharmacology | Glutamic Acid - metabolism | Valine - pharmacology | In Vitro Techniques | Nitric Oxide - metabolism | GTP-Binding Proteins - metabolism | Gβγ
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2005, Volume 102, Issue 52, pp. 19144 - 19149
Journal Article
Journal Article
PSYCHOPHARMACOLOGY, ISSN 0033-3158, 10/2016, Volume 233, Issue 21-22, pp. 3685 - 3709
Rationale AKB48 and its fluorinate derivate 5F-AKB48 are two novel synthetic cannabinoids belonging to a structural class with an indazole core structure. They... 
EXTRACELLULAR DOPAMINE | PRIMARY SOMATOSENSORY CORTEX | SAFETY PHARMACOLOGY | AGGRESSIVE-BEHAVIOR | PREPULSE INHIBITION | PSYCHIATRY | EVOKED ACTIVITY | AKB48 | JWH-018 | NEUROSCIENCES | MASS-SPECTROMETRY | Cannabinoids | NOCICEPTIN/ORPHANIN FQ TRANSMISSION | 5F-AKB48 | Microdialysis | Sensorimotor responses | Synthetic cannabinoids | Delta-THC | PHARMACOLOGY & PHARMACY | NUCLEUS-ACCUMBENS SHELL | Behavior | RECEPTOR AGONIST | Humans | Nucleus Accumbens - metabolism | Motor Activity - drug effects | Male | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Cannabinoid Receptor Agonists - pharmacology | Seizures - chemically induced | Cannabis | Piperidines - pharmacology | Cannabinoid Receptor Antagonists - pharmacology | Catalepsy - chemically induced | Pain Threshold - drug effects | Behavior, Animal - drug effects | Indoles - pharmacology | Reflex, Abnormal - drug effects | Dronabinol - pharmacology | Dopamine - metabolism | Adamantane - analogs & derivatives | Pyrazoles - pharmacology | Binding, Competitive | Adamantane - pharmacology | Naphthalenes - pharmacology | Indazoles - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Mice | In Vitro Techniques | Nucleus Accumbens - drug effects | Aggression - drug effects | Pharmacology, Experimental | Research | Neurochemistry | Psychotropic drugs | Neurology | Pharmacology | Rodents
Journal Article
Advances in experimental medicine and biology, ISSN 0065-2598, 2019, Volume 1162, p. 151
The Cannabis plant has been used for many of years as a medicinal agent in the relief of pain and seizures. It contains approximately 540 natural compounds... 
Medical Marijuana - pharmacology | Cannabis | Humans | Cannabidiol - pharmacology | Dronabinol - pharmacology
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2007, Volume 152, Issue 5, pp. 734 - 743
Background and purpose: Although CB1 receptor activation evokes neuroprotection in response to cannabinoids, some cannabinoids have been reported to be... 
Neuroprotection | Peroxisome proliferator-activated receptors (PPARs) | Cannabinoids | N-oleoylethanolamine | GAMMA | CELLS | FOCAL CEREBRAL-ISCHEMIA | ANANDAMIDE | ENDOCANNABINOID SYSTEM | NUCLEAR RECEPTOR | peroxisome proliferator-activated receptors (PPARs) | neuroprotection | cannabinoids | THERAPEUTIC TARGETS | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | TRANSCRIPTION FACTOR | BRAIN | Luciferases - metabolism | Humans | Benzoxazines - metabolism | Male | Recombinant Fusion Proteins - metabolism | Cerebral Cortex - metabolism | Neuroprotective Agents - metabolism | Luciferases - genetics | Oleic Acids - metabolism | Arachidonic Acids - metabolism | Fenofibrate - pharmacology | Neuroprotective Agents - pharmacology | Transfection | I-kappa B Kinase - metabolism | Cerebral Cortex - drug effects | Oleic Acids - pharmacology | Dronabinol - pharmacology | Naphthalenes - metabolism | Cannabinoids - metabolism | Endocannabinoids | Fenofibrate - metabolism | Mice, Inbred C57BL | Morpholines - pharmacology | Fatty Acids, Unsaturated - pharmacology | Morpholines - metabolism | PPAR alpha - genetics | Polyunsaturated Alkamides - metabolism | Arachidonic Acids - pharmacology | Cannabinoids - pharmacology | Mice, Knockout | Naphthalenes - pharmacology | Animals | Benzoxazines - pharmacology | Cyclooxygenase 2 - metabolism | Polyunsaturated Alkamides - pharmacology | Protein Binding | Recombinant Fusion Proteins - genetics | Ligands | PPAR alpha - agonists | Mice | HeLa Cells | PPAR alpha - metabolism | Dronabinol - metabolism | Research Papers
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 2014, Volume 289, Issue 36, pp. 24845 - 24862
Modulation of type 1 cannabinoid receptor (CB1) activity has been touted as a potential means of treating addiction, anxiety, depression, and... 
INTERNALIZATION | CANNABIDIOL | MAP KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | G-PROTEINS | ENDOCANNABINOID SYSTEM | DOWN-REGULATION | RESONANCE ENERGY-TRANSFER | HUNTINGTONS-DISEASE | CB1 RECEPTOR | AGONIST | Endocannabinoids - pharmacology | Neurons - cytology | Dendritic Spines - metabolism | Cannabinoid Receptor Agonists - pharmacology | Corpus Striatum - cytology | Corpus Striatum - metabolism | Receptor, Cannabinoid, CB1 - agonists | Fluorescence Resonance Energy Transfer | Neurons - metabolism | Cyclohexanols - pharmacology | Dronabinol - pharmacology | Arrestin - metabolism | Arrestin - genetics | Cells, Cultured | Morpholines - pharmacology | Arachidonic Acids - pharmacology | Blotting, Western | Cannabinoids - pharmacology | Naphthalenes - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Glycerides - pharmacology | Animals | Receptor, Cannabinoid, CB1 - genetics | Signal Transduction - drug effects | Models, Biological | Benzoxazines - pharmacology | Polyunsaturated Alkamides - pharmacology | Ligands | Luminescent Proteins - genetics | Mice | GTP-Binding Proteins - metabolism | Luminescent Proteins - metabolism | 2-Arachidonylglycerol | Anandamide (N-Arachidonoylethanolamine) (AEA) | Bioluminescence Resonance Energy Transfer (BRET) | Neurobiology | Cell Signaling | Cannabidiol | Arrestin | Cannabinoid | Cannabinoid Receptor | Δ9-tetrahydrocannabinol (THC)
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2014, Volume 82, pp. 69 - 75
Journal Article